Agency Forms Undergoing Paperwork Reduction Act Review, 50153-50155 [2023-16220]
Download as PDF
Federal Register / Vol. 88, No. 146 / Tuesday, August 1, 2023 / Notices
FEDERAL RESERVE SYSTEM
lotter on DSK11XQN23PROD with NOTICES1
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors,
Ann E. Misback, Secretary of the Board,
20th Street and Constitution Avenue
NW, Washington, DC 20551–0001, not
later than August 30, 2023.
A. Federal Reserve Bank of San
Francisco: (Joseph Cuenco, Assistant
Vice President, Formations,
Transactions & Enforcement) 101
Market Street, San Francisco, California
94105–1579. Comments can also be sent
electronically to:
sf.fisc.comments.applications@
sf.frb.org.
1. VB&T Holding Company, LLC,
Scottsdale, Arizona; through its wholly
owned subsidiary, VB&T Wealth
Management LLC dba Zenith Wealth
Advisors, Scottsdale, Arizona, to engage
in wealth management services,
pursuant to section 225.28(b)(5) and
(b)(6) of the Board’s Regulation Y.
VerDate Sep<11>2014
18:34 Jul 31, 2023
Jkt 259001
Board of Governors of the Federal Reserve
System.
Erin M. Cayce,
Assistant Secretary of the Board.
[FR Doc. 2023–16234 Filed 7–31–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1072]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘STD
Surveillance Network (SSuN)’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 10, 2023 to obtain
comments from the public and affected
agencies. CDC received two comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
50153
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
The STD Surveillance Network
(SSuN), (OMB Control No. 0920–1072,
Exp. 10/31/2023)—Revision—National
Center for HIV/, Viral Hepatitis, STD,
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS,
Viral Hepatitis, STD and TB Prevention
(NCHSTP) is requesting a Revision of
the Information Collection Request (ICR)
titled, The STD Surveillance Network
(SSuN). Revisions to this submission
include addition of mpox-related data
elements for monitoring mpox risk,
vaccination, diagnoses, and laboratory
testing as part of ongoing surveillance
for this emergent public health issue.
Additionally, this Revision ICR
incorporates future expansion of SSuN
to additional STD clinical facilities,
addition of several new data elements to
sentinel surveillance activities in STD
clinical facilities related to Pre-Exposure
Prophylaxis for HIV (PrEP), and
enhanced investigations of a random
sample syphilis cases reported to
participating health departments.
Multiple data elements associated with
enhanced gonorrhea case investigations
and provider reporting forms are also
being retired. The estimate of
annualized burden hours for this
revised data collection increases from
5,863 hours to 7,487 hours.
The purpose of this project is to
enhance national capacity for STD
surveillance and to better meet CDC’s
disease surveillance mandate by: (1)
addressing gaps in epidemiologicallyrelevant information by providing more
complete behavioral and demographic
data on reported cases of notifiable
STDs to enhance the ability of public
health authorities to interpret trends in
case incidence, assess inequalities in the
burden of disease by population
E:\FR\FM\01AUN1.SGM
01AUN1
lotter on DSK11XQN23PROD with NOTICES1
50154
Federal Register / Vol. 88, No. 146 / Tuesday, August 1, 2023 / Notices
characteristics and to monitor STD
treatment and selected adverse health
outcomes of STDs; (2) monitoring STD
and HIV co-infection, screening, uptake
of STD and HIV prevention
interventions and health care access
trends among patients seeking care for,
and those diagnosed with, STDs in
specialty clinical settings; and (3)
providing a robust sentinel monitoring
system for newly emergent and/or reemergent health threats such as mpox.
Routine STD case surveillance
activities are ongoing in all US
jurisdictions. Cases diagnosed in U.S.
jurisdictions are voluntarily reported to
CDC through the National Notifiable
Diseases Surveillance System (NNDSS)
and case data are collaboratively
defined in cooperation with the Council
of State and Territorial Epidemiologists
(CSTE). However, case data received by
CDC through NNDSS are increasingly
missing required patient demographics
and are extremely limited in scope with
respect to risk behaviors, treatments
prescribed, co-infection with other
infections, preventive services, and
sexual network characteristics. These
data are needed to monitor incidence
and prevalence and to inform
prevention and control efforts.
Additionally, clinical information on
patients seeking STD-specific care in
specialty STD clinics is not available
through any other national medical
record abstracts or data sources. These
data are critical to detecting emergent
STD-related sequela or reemergence of
mpox, appropriately informing local
disease control activities and to inform
analyses of national trends in the
epidemiology of STD incidence. These
data are also useful to monitor care
services in essential safety-net STD
clinics and evaluate local and national
STD prevention and control measures.
SSuN is the only surveillance
infrastructure providing such
comprehensive, representative
information on patient and sex-partner
characteristics, clinical presentation,
STD screenings, uptake of HIV testing,
screening for and uptake of mpox
vaccine in STD clinics, curative and
preventive treatment patterns, provider
compliance with treatment
recommendations, HIV co-infection
among persons diagnosed with STDs
and uptake of STD and HIV prevention
interventions such as pre-exposure
prophylaxis for HIV (PrEP) and/or PostExposure Prophylaxis (PEP) for bacterial
STDs. These measures are key elements
of the U.S. national strategy to End the
HIV Epidemic (EHE) and support the
Sexually Transmitted Infections,
National Strategic Plan for the United
States.
VerDate Sep<11>2014
18:34 Jul 31, 2023
Jkt 259001
The STD Surveillance Network was
established in 2005 as a network of six
initially funded state and local public
health agencies providing more
comprehensive STD case-level and
clinical facility information. In 2008,
SSuN was expanded to 12 recipients to
add important geographic diversity and
to include visit-level data on a full
census of patients being seen in
categorical STD clinics. The network’s
activities were continued in a third
funding cycle in 2013, with 10
recipients conducting core data
collection activities in STD clinics and
among a random sample of reported
cases.
The current project, SSuN Cycle 4
(2019–2024), comprises 11 U.S. local/
state health departments, including
Baltimore City Health Department,
California Department of Public Health,
City of Columbus Public Health
Department, Florida Department of
Health, Indiana Department of Public
Health, Multnomah County Health
Department, New York City Department
of Health & Mental Hygiene,
Philadelphia Department of Public
Health, San Francisco Department of
Public Health, Utah Department of
Public Health and Washington State
Department of Health.
SSuN Cycle 4 continues to provide
critical information addressing CDC’s
Division of Sexually Transmitted
Disease (DSTDP) priorities as articulated
in the STI National Strategic Plan,
including contributing data to CDC’s
annual STD Surveillance Report, CDC’s
quarterly progress indicators and
contributing to the body of literature
related to STDs. Trend data across
multiple cycles of SSuN are frequently
used to inform policy discussions on
prevention and treatment
recommendations for common bacterial
STDs. Of particular importance, SSuN
provides data on use of pre- and postexposure prophylaxis to prevent STDs
and HIV infection (PEP and PrEP). SSuN
also provides documentation of critical
changes in clinical services provided by
specialty STD clinics, and on the
proportion of cases treated with
appropriate antimicrobial regimens, an
essential indicator of compliance with
CDC treatment recommendations to
combat the emergence of antimicrobial
resistance (AMR). More recently, SSuN
data have also been invaluable in
assessing COVID–19 and mpox impacts
on reported case incidence and patient
access and care-seeking patterns and
provides a reliable monitoring
infrastructure for mpox re-emergence.
STD clinics were the front-line provider
of choice for persons suspecting mpox
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
infection or seeking preventive services
such as mpox vaccination.
Data collection components of SSuN
are grouped into two primary strategies,
reflecting different sentinel and
enhanced population-based surveillance
methods and activities. Strategy A
includes sentinel surveillance in STD
clinics to monitor patient care,
screening and diagnostic practices, HIV
co-infection, treatment and STD-related
HIV prevention services delivered to
patients. In collaboration with
participating local/state health
departments and their clinical partners,
SSuN implements consensus protocols
to collect demographic, clinical and risk
behavior data on patients presenting for
care in selected specialty STD clinics.
Records for patients presenting for care
are also matched to the jurisdiction’s
HIV surveillance registry, providing
data on HIV co-infection not currently
available from any other multijurisdictional source. Data for these
activities are abstracted from existing
electronic medical records at
participating STD clinics, leveraging
information that is already collected in
the provision of routine STD clinical
care. All records are fully de-identified
by collaborating facilities or health
departments and transmitted to CDC
through secure file transport
mechanisms six times annually. The
estimated time for the clinic data
managers to abstract/recode data is four
hours every two months. The current
Revision anticipates expansion of this
activity from the current 15 clinics to up
to 40 STD clinics beginning in 2024
with a resulting burden of 960 hours (40
× 4 hours × 6 times/year). Previously
approved clinic patient survey is no
longer required and will only be
implemented by clinics on a local use/
need basis; number of responses are
reduced to 1,000 with a corresponding
reduction in burden hours.
The second core data collection
activity, Strategy B, currently includes:
(1) abstraction recoding and reporting of
all gonorrhea and syphilis cases
reported in the collaborating
jurisdiction; (2) enhanced investigations
on a random sample of all persons
diagnosed with gonorrhea or syphilis;
and (3) health department abstraction
and registry matching for a complete
census of reported gonorrhea and
syphilis cases. For the first activity, a
random sample of all gonorrhea cases
diagnosed and reported to health
departments within the participating
jurisdictions are selected for enhanced
investigations. Beginning in 2024, these
investigations will be expanded to
include a random sample of reported
syphilis cases, include abstracting
E:\FR\FM\01AUN1.SGM
01AUN1
50155
Federal Register / Vol. 88, No. 146 / Tuesday, August 1, 2023 / Notices
clinical data from diagnosing providers,
matching cases with existing health
department disease registries and brief
patient demographic and behavioral
interviews (10 minutes per response).
The population of interest includes all
persons diagnosed and reported with
gonorrhea and syphilis; existing case
records are matched to other health
department disease registries to
determine co-infections and to
document laboratory and treatment
information known by the health
department through routine case
investigations and local laboratory
reporting. In the proposed Revision,
syphilis cases will also be selected for
enhanced provider and patient
investigations utilizing the same
consensus protocols used for enhanced
gonorrhea case investigations.
Considering recent increases in syphilis
cases in the U.S., especially congenital
syphilis, these data are critical to
informing local and national syphilis
prevention and control activities. SSuN
recipients implement protocols
providing uniformly coded data on
demographic characteristics, behavioral
risk factors, clinical care, laboratory data
and health care seeking behaviors that
are combined into a national dataset
following data quality assurance at CDC.
In 2021, there were 211,791 cases of
gonorrhea diagnosed and reported
across the 11 current recipients of
SSuN. Approximately 7.4%, or 15,715
cases were randomly sampled for
enhanced investigation; full enhanced
investigations were completed for 6,186
(39.4%). During the COVID–19 public
health emergency, a slightly larger
proportion of cases were lost to followup than in prior years due to local
staffing shortages, issues with timely
laboratory and case reporting, and
higher than average patient refusals. No
additional burden is anticipated from
the future inclusion of early syphilis
cases in Strategy B because of the
decrease in gonorrhea case
investigations.
Data managers at each of the local/
state health departments or clinical
facilities receiving funding are
responsible for transmitting validated
datasets for these activities to CDC every
other month. This reflects 5,280 burden
hours for Strategy A and B data
management (11 respondents x 12 data
transmissions x 40 hours per data
transmission), which includes
automated HIV registry matching which
was previously included as a separate
activity; burden for this previously
approved component as a separate
activity is reduced to zero.
The total estimated annual burden
hours are 7,487 for SSuN. Respondents
from local/state health departments
and/or clinical facilities receive federal
funds to participate in this project.
There are no costs to patients or
respondents other than their time and
no risk or penalty for non-participation.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Data managers at sentinel STD clinics ..........
General Public—Adults (persons diagnosed
with gonorrhea).
Data Managers: local/state health departments (strategy A).
Electronic Clinical Record Abstraction ...........
Patient interviews for a random sample of
gonorrhea and syphilis cases.
Data cleaning/validation, HIV registry matching and data transmissions for all activity
components.
Data cleaning/validation, HIV registry matching and data transmissions for all activity
components.
Clinic waiting room surveys ...........................
Data Managers: local/state health departments (strategy B).
General Public—Adults (persons presenting
for care in STD Clinics).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–16220 Filed 7–31–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
[60Day–23–0260; Docket No. CDC–2023–
0065]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
18:34 Jul 31, 2023
Jkt 259001
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Health Hazard
Evaluations/Technical Assistance and
Emerging Problems. This data collection
is designed to assist the National
Institute for Occupational Safety and
Health (NIOSH) in responding to
requests for Health Hazard Evaluations
(HHEs) to identify chemical, biological
or physical hazards in workplaces
throughout the United States.
SUMMARY:
CDC must receive written
comments on or before October 2, 2023.
DATES:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average hours
per response
40
7,000
6
1
4
10/60
11
6
40
11
6
40
1000
1
5/60
Number of
respondents
Type of respondent
You may submit comments,
identified by Docket No. CDC–2023–
0065 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
ADDRESSES:
E:\FR\FM\01AUN1.SGM
01AUN1
Agencies
[Federal Register Volume 88, Number 146 (Tuesday, August 1, 2023)]
[Notices]
[Pages 50153-50155]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16220]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1072]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``STD Surveillance Network (SSuN)'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on March 10, 2023 to obtain
comments from the public and affected agencies. CDC received two
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
The STD Surveillance Network (SSuN), (OMB Control No. 0920-1072,
Exp. 10/31/2023)--Revision--National Center for HIV/, Viral Hepatitis,
STD, TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHSTP) is requesting a Revision of the Information
Collection Request (ICR) titled, The STD Surveillance Network (SSuN).
Revisions to this submission include addition of mpox-related data
elements for monitoring mpox risk, vaccination, diagnoses, and
laboratory testing as part of ongoing surveillance for this emergent
public health issue. Additionally, this Revision ICR incorporates
future expansion of SSuN to additional STD clinical facilities,
addition of several new data elements to sentinel surveillance
activities in STD clinical facilities related to Pre-Exposure
Prophylaxis for HIV (PrEP), and enhanced investigations of a random
sample syphilis cases reported to participating health departments.
Multiple data elements associated with enhanced gonorrhea case
investigations and provider reporting forms are also being retired. The
estimate of annualized burden hours for this revised data collection
increases from 5,863 hours to 7,487 hours.
The purpose of this project is to enhance national capacity for STD
surveillance and to better meet CDC's disease surveillance mandate by:
(1) addressing gaps in epidemiologically-relevant information by
providing more complete behavioral and demographic data on reported
cases of notifiable STDs to enhance the ability of public health
authorities to interpret trends in case incidence, assess inequalities
in the burden of disease by population
[[Page 50154]]
characteristics and to monitor STD treatment and selected adverse
health outcomes of STDs; (2) monitoring STD and HIV co-infection,
screening, uptake of STD and HIV prevention interventions and health
care access trends among patients seeking care for, and those diagnosed
with, STDs in specialty clinical settings; and (3) providing a robust
sentinel monitoring system for newly emergent and/or re-emergent health
threats such as mpox.
Routine STD case surveillance activities are ongoing in all US
jurisdictions. Cases diagnosed in U.S. jurisdictions are voluntarily
reported to CDC through the National Notifiable Diseases Surveillance
System (NNDSS) and case data are collaboratively defined in cooperation
with the Council of State and Territorial Epidemiologists (CSTE).
However, case data received by CDC through NNDSS are increasingly
missing required patient demographics and are extremely limited in
scope with respect to risk behaviors, treatments prescribed, co-
infection with other infections, preventive services, and sexual
network characteristics. These data are needed to monitor incidence and
prevalence and to inform prevention and control efforts.
Additionally, clinical information on patients seeking STD-specific
care in specialty STD clinics is not available through any other
national medical record abstracts or data sources. These data are
critical to detecting emergent STD-related sequela or reemergence of
mpox, appropriately informing local disease control activities and to
inform analyses of national trends in the epidemiology of STD
incidence. These data are also useful to monitor care services in
essential safety-net STD clinics and evaluate local and national STD
prevention and control measures. SSuN is the only surveillance
infrastructure providing such comprehensive, representative information
on patient and sex-partner characteristics, clinical presentation, STD
screenings, uptake of HIV testing, screening for and uptake of mpox
vaccine in STD clinics, curative and preventive treatment patterns,
provider compliance with treatment recommendations, HIV co-infection
among persons diagnosed with STDs and uptake of STD and HIV prevention
interventions such as pre-exposure prophylaxis for HIV (PrEP) and/or
Post-Exposure Prophylaxis (PEP) for bacterial STDs. These measures are
key elements of the U.S. national strategy to End the HIV Epidemic
(EHE) and support the Sexually Transmitted Infections, National
Strategic Plan for the United States.
The STD Surveillance Network was established in 2005 as a network
of six initially funded state and local public health agencies
providing more comprehensive STD case-level and clinical facility
information. In 2008, SSuN was expanded to 12 recipients to add
important geographic diversity and to include visit-level data on a
full census of patients being seen in categorical STD clinics. The
network's activities were continued in a third funding cycle in 2013,
with 10 recipients conducting core data collection activities in STD
clinics and among a random sample of reported cases.
The current project, SSuN Cycle 4 (2019-2024), comprises 11 U.S.
local/state health departments, including Baltimore City Health
Department, California Department of Public Health, City of Columbus
Public Health Department, Florida Department of Health, Indiana
Department of Public Health, Multnomah County Health Department, New
York City Department of Health & Mental Hygiene, Philadelphia
Department of Public Health, San Francisco Department of Public Health,
Utah Department of Public Health and Washington State Department of
Health.
SSuN Cycle 4 continues to provide critical information addressing
CDC's Division of Sexually Transmitted Disease (DSTDP) priorities as
articulated in the STI National Strategic Plan, including contributing
data to CDC's annual STD Surveillance Report, CDC's quarterly progress
indicators and contributing to the body of literature related to STDs.
Trend data across multiple cycles of SSuN are frequently used to inform
policy discussions on prevention and treatment recommendations for
common bacterial STDs. Of particular importance, SSuN provides data on
use of pre- and post-exposure prophylaxis to prevent STDs and HIV
infection (PEP and PrEP). SSuN also provides documentation of critical
changes in clinical services provided by specialty STD clinics, and on
the proportion of cases treated with appropriate antimicrobial
regimens, an essential indicator of compliance with CDC treatment
recommendations to combat the emergence of antimicrobial resistance
(AMR). More recently, SSuN data have also been invaluable in assessing
COVID-19 and mpox impacts on reported case incidence and patient access
and care-seeking patterns and provides a reliable monitoring
infrastructure for mpox re-emergence. STD clinics were the front-line
provider of choice for persons suspecting mpox infection or seeking
preventive services such as mpox vaccination.
Data collection components of SSuN are grouped into two primary
strategies, reflecting different sentinel and enhanced population-based
surveillance methods and activities. Strategy A includes sentinel
surveillance in STD clinics to monitor patient care, screening and
diagnostic practices, HIV co-infection, treatment and STD-related HIV
prevention services delivered to patients. In collaboration with
participating local/state health departments and their clinical
partners, SSuN implements consensus protocols to collect demographic,
clinical and risk behavior data on patients presenting for care in
selected specialty STD clinics. Records for patients presenting for
care are also matched to the jurisdiction's HIV surveillance registry,
providing data on HIV co-infection not currently available from any
other multi-jurisdictional source. Data for these activities are
abstracted from existing electronic medical records at participating
STD clinics, leveraging information that is already collected in the
provision of routine STD clinical care. All records are fully de-
identified by collaborating facilities or health departments and
transmitted to CDC through secure file transport mechanisms six times
annually. The estimated time for the clinic data managers to abstract/
recode data is four hours every two months. The current Revision
anticipates expansion of this activity from the current 15 clinics to
up to 40 STD clinics beginning in 2024 with a resulting burden of 960
hours (40 x 4 hours x 6 times/year). Previously approved clinic patient
survey is no longer required and will only be implemented by clinics on
a local use/need basis; number of responses are reduced to 1,000 with a
corresponding reduction in burden hours.
The second core data collection activity, Strategy B, currently
includes: (1) abstraction recoding and reporting of all gonorrhea and
syphilis cases reported in the collaborating jurisdiction; (2) enhanced
investigations on a random sample of all persons diagnosed with
gonorrhea or syphilis; and (3) health department abstraction and
registry matching for a complete census of reported gonorrhea and
syphilis cases. For the first activity, a random sample of all
gonorrhea cases diagnosed and reported to health departments within the
participating jurisdictions are selected for enhanced investigations.
Beginning in 2024, these investigations will be expanded to include a
random sample of reported syphilis cases, include abstracting
[[Page 50155]]
clinical data from diagnosing providers, matching cases with existing
health department disease registries and brief patient demographic and
behavioral interviews (10 minutes per response). The population of
interest includes all persons diagnosed and reported with gonorrhea and
syphilis; existing case records are matched to other health department
disease registries to determine co-infections and to document
laboratory and treatment information known by the health department
through routine case investigations and local laboratory reporting. In
the proposed Revision, syphilis cases will also be selected for
enhanced provider and patient investigations utilizing the same
consensus protocols used for enhanced gonorrhea case investigations.
Considering recent increases in syphilis cases in the U.S., especially
congenital syphilis, these data are critical to informing local and
national syphilis prevention and control activities. SSuN recipients
implement protocols providing uniformly coded data on demographic
characteristics, behavioral risk factors, clinical care, laboratory
data and health care seeking behaviors that are combined into a
national dataset following data quality assurance at CDC.
In 2021, there were 211,791 cases of gonorrhea diagnosed and
reported across the 11 current recipients of SSuN. Approximately 7.4%,
or 15,715 cases were randomly sampled for enhanced investigation; full
enhanced investigations were completed for 6,186 (39.4%). During the
COVID-19 public health emergency, a slightly larger proportion of cases
were lost to follow-up than in prior years due to local staffing
shortages, issues with timely laboratory and case reporting, and higher
than average patient refusals. No additional burden is anticipated from
the future inclusion of early syphilis cases in Strategy B because of
the decrease in gonorrhea case investigations.
Data managers at each of the local/state health departments or
clinical facilities receiving funding are responsible for transmitting
validated datasets for these activities to CDC every other month. This
reflects 5,280 burden hours for Strategy A and B data management (11
respondents x 12 data transmissions x 40 hours per data transmission),
which includes automated HIV registry matching which was previously
included as a separate activity; burden for this previously approved
component as a separate activity is reduced to zero.
The total estimated annual burden hours are 7,487 for SSuN.
Respondents from local/state health departments and/or clinical
facilities receive federal funds to participate in this project. There
are no costs to patients or respondents other than their time and no
risk or penalty for non-participation.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
Data managers at sentinel STD clinics. Electronic Clinical 40 6 4
Record Abstraction.
General Public--Adults (persons Patient interviews for a 7,000 1 10/60
diagnosed with gonorrhea). random sample of
gonorrhea and syphilis
cases.
Data Managers: local/state health Data cleaning/ 11 6 40
departments (strategy A). validation, HIV
registry matching and
data transmissions for
all activity components.
Data Managers: local/state health Data cleaning/ 11 6 40
departments (strategy B). validation, HIV
registry matching and
data transmissions for
all activity components.
General Public--Adults (persons Clinic waiting room 1000 1 5/60
presenting for care in STD Clinics). surveys.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-16220 Filed 7-31-23; 8:45 am]
BILLING CODE 4163-18-P